Author

N. Kreif

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2020

Who benefits from health insurance? Uncovering heterogeneous policy impacts using causal machine learning

This study demonstrates the power of CML approaches to uncover the heterogeneity in programme impacts, hence providing policymakers with valuable information for programme design.

N. Kreif, A. Mirelman, Rodrigo Antonio Moreno Serra et al. · White Rose Research Online (... · 0 citations

Open access Oct 2026

Real-World Comparative Effectiveness of Abiraterone, Apalutamide, Enzalutamide, and Docetaxel Doublets for Metastatic Hormone-Sensitive Prostate Cancer.

PURPOSE To evaluate the real-world comparative effectiveness of androgen receptor pathway inhibitors (ARPIs)-abiraterone, apalutamide, enzalutamide-and docetaxel, plus androgen-deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC). METHODS We identified US men with mHSPC who initiated ADT...

I. B. Nwogu, N. Kreif, Hiba M. Khan et al. · JCO Oncology Practice · 0 citations